Ihara, Eikichi http://orcid.org/0000-0002-7070-6610
Ogino, Haruei
Muta, Kazumasa
Hamada, Shohei
Wada, Masafumi
Hata, Yoshitaka
Ikeda, Hiroko
Bai, Xiaopeng
Minoda, Yosuke
Esaki, Mitsuru
Tanaka, Yoshimasa
Chinen, Takatoshi
Ogawa, Yoshihiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19lk0201088h0001, 21lk0201144h0001)
Japan Society for the Promotion of Science (20K08334)
Article History
Received: 11 June 2021
Accepted: 6 October 2021
First Online: 9 October 2021
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: E.I. belongs to an endowed course supported by the companies including Ono pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co. Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Fujifilm Medical Co., Ltd., Terumo corporation, FANCL corporation, Ohga pharmacy, and Abbott Japan, LLC. E.I. receives lecture honorarium from Takeda Pharmaceutical Company. Y.O. conducts collaborative research with Fujifilm Medical Co., Ltd. and FANCL corporation. H.O., K.M., S.H., M.W., Y.H., H.I., X.B.,Y.M., M.E., Y.T., and T.C. declare no conflict of interest in association with this study.